Bridge Legal

Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Fate of most remaining Zantac lawsuits weighed by Delaware judge GSK , Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.